Media center

If you are covering the UK International Development Committee’s FCDO Equality Impact Assessment, and the implications for global sexual and reproductive health and rights, you may find the below statement from the International Planned Parenthood Federation helpful: The UK’s brutal cuts are a tragic blow for the world's poorest and most marginalized women and girls.    The assessment outlines cuts to the department's Overseas Development Assistance budget worth more than £900m for this year, including allocated funding for vital sexual and reproductive health services.   In particular, IPPF faces cuts to its flagship programme: the Women's Integrated Sexual Health Programme (WISH), which delivers life-saving contraception and sexual and reproductive health services for women and girls in some of the world’s poorest and most marginalized communities. At inception in 2018 the programme delivered services across 15 countries in Africa and South Asia but had to scale down due to budget cuts with Bangladesh, Zimbabwe and Zambia closing out in August 2021. Mozambique closed out in September 2021 and Afghanistan in December 2021. Finally, Pakistan closed out in 2022, leaving the programme running in nine countries in sub-Saharan Africa at a smaller scale.   The 2022-2023 budget cut of over 50% has seen further scaling down of in-country programmes resulting in lowered programme implementation coverage with reduced health facility support, reduced community outreaches, reduced community engagement and overall reduced access to sexual and reproductive services to the most marginalised groups.  According to the latest assessment, cuts to WISH will reduce protection for women with "the number of unsafe abortions averted from nearly 300,000 to approximately 115,000; number of maternal deaths averted will drop from 2,531 to just over 1,000".  Mina Barling, IPPF’s Director of External Relations said:  “As we warned in 2021 and as demonstrated in the government’s own assessment, the devastating cuts to IPPF’s flagship programme in Africa and Asia mean thousands of women and girls will die - many from the indignity of an unsafe abortion, or in childbirth. To add further insult to injury, it has now left the most marginalised exposed to an aggressive opposition.   The UK aid cuts did not happen in isolation. They compounded a transnational far-right regime that began during President Trump’s reign in the United States. In the most extraordinary of circumstances, the space left by civil society meant autocratic actors were now able to move rapidly, shrinking democratic space, and in doing so, exploiting new opportunities to further embed an anti-rights agenda.   It is no coincidence that this has happened in countries (such as Uganda and Kenya) where the UK government had been a critical partner, where we are watching as anti-LGBTIQ+ legislation translates into increased violence and threatens incarceration and even the death penalty. This is a moment of crisis, which if left unaddressed, is an open invitation to others to replicate vitriolic policies, legislation and narratives.  We are reaching a tipping point. We must connect the dots and take action now. We implore the UK government to restore its aid budget to pre-pandemic levels of 0.7% of Gross National Income. We urgently need the UK’s leadership, support, and investment so that IPPF and its partners can continue providing critical care where it is most needed. The lives of millions depend on it."  Fact box  Since its launch in 2018 and the end of December 2022, the WISH programme prevented an estimated:    12.2 million unintended pregnancies    4.1 million unsafe abortions    20,500 maternal deaths                               Today, 218 million women want to access contraception but can't access it  35 million women each year still resort to an unsafe abortion.    20 million adolescents face an unmet need for contraception. For girls aged 15-19, pregnancy and childbirth complications are the leading cause of death globally.    Pregnancy and marriage are the main reasons why adolescent girls drop out of school, and Africa has the highest adolescent pregnancy rate in the world.    As a result of the pandemic, 12 million women and girls have lost access to contraception, leading to 1.4 million unintended pregnancies. This is what happens when access to SRHR care is uninterrupted.      About WISH  The Women’s Integrated Sexual Health (WISH) programme is the UK Foreign, Commonwealth and Development Office’s (FCDO) largest Sexual and Reproductive Health and Rights (SRHR) delivery programme. The WISH programme delivers progress towards UK commitments on universal SRHR and Sustainable Development Goals (SDGs) targets by contributing to reductions in maternal deaths, unsafe abortions, and unintended pregnancies in Africa and South Asia.   The Lot 2 WISH consortium (W2A) is led by International Planned Parenthood Federation (IPPF) with Marie Stopes Reproductive Choices (MSI), International Rescue Committee (IRC), Development Media International (DMI), Options, and Humanity and Inclusion (HI).    In the project’s first phase, the WISH2ACTION Consortium operated in the following countries: Afghanistan, Bangladesh, Burundi, Ethiopia, Madagascar, Malawi, Mozambique, Pakistan, Somalia, South Sudan, Sudan, Tanzania, Uganda, Zambia and Zimbabwe. For the second phase, the project has continued across Burundi, Ethiopia, Madagascar, Malawi, Somalia, South Sudan, Sudan, Tanzania and Uganda.  About the International Planned Parenthood Federation  The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.    For over 65 years, IPPF, through its 118 Member Associations and 15 partners, has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context.  We advocate for a world where people are provided with the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.  For media inquiries please contact [email protected]   

The International Planned Parenthood Federation Africa Region (IPPFAR) is appalled and deeply disturbed by the recent enactment of the anti-homosexuality act 2023 by President Museveni of Uganda. This regressive law represents a grave violation of human rights and sexual and reproductive rights, affecting not only the LGBTIQ+ community but all Ugandans. The draconian and abhorrent provisions of this law criminalize same-sex relationships and any promotion of homosexuality, subjecting individuals to severe penalties, including life imprisonment. Its implementation will have dire consequences, fostering a climate of homophobia, hatred, and hate crimes. The law instills fear not only among those directly targeted and their families but also among health workers providing essential Sexual and Reproductive Health (SRH) services in Uganda. IPPFAR is extremely concerned that this law blatantly violates numerous human rights, including the right to bodily autonomy. The right to life and dignity, freedom of expression and association, protection from discrimination, the right to a fair trial, protection against arbitrary arrest, and access to health services are all undermined, compromising the full realization of sexual and reproductive health and rights. "The IPPF Africa region vehemently condemns the anti-homosexuality act 2023, which targets the LGBTIQ+ community and their allies in Uganda. This law marks a sorrowful day for Uganda and its people," stated Marie-Evelyne Petrus-Barry, IPPF Africa Regional Director. "Targeting a community based solely on their shared characteristics is extremely dangerous and an undeniable violation of human rights. Instead, we should strive to empower all members of our society to be positive contributors, rather than driving them into hiding and marginalization," Petrus-Barry added. Since March 2023, IPPF has witnessed a surge in physical attacks against the LGBTIQ+ community, threats to the safety of civil society organizations, and an alarming increase in hate speech targeting LGBTIQ+ individuals and their allies. The anti-homosexuality act 2023 is discriminatory and flagrantly violates the fundamental freedoms enshrined in the Uganda constitution. By isolating itself from the international community, Uganda risks alienating potential collaborators and donors. Already, the U.S. Government has expressed intentions to suspend development funding to Uganda, including through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund and UNAIDs, potentially jeopardizing the progress in the fight against the HIV pandemic in Uganda. As the foremost provider of sexual and reproductive health (SRH) services in Africa, IPPFAR is immensely concerned that this law will deter individuals from seeking vital SRH services due to fear of being targeted. This will inevitably hinder access to life-saving services, including HIV/AIDS testing and treatment, provision of antiretroviral therapy, contraceptive services, and accurate SRH information. Moreover, the law obstructs healthcare professionals from fulfilling their duties and providing high-quality care in a safe and confidential environment. IPPFAR joins the chorus of condemnation against this harmful and regressive law. The safety, health, and dignity of all Ugandans must remain paramount. IPPF stands resolutely with the LGBTIQ+ community and their allies in Uganda and worldwide during this challenging time.   For media enquiries, please contact [email protected]   About the International Planned Parenthood Federation The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.  For 70 years, IPPF, through its 118 Member Associations and seven partners, has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context. We advocate for a world where people have the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.

Texas judge, Matthew Kacsmaryk, has suspended the U.S. Food and Drug Administration's (FDA) approval of the abortion pill Mifepristone in a horror move for abortion access across the United States. The decision will result in a nationwide ban on Mifepristone in seven days, with the FDA given one week to appeal the ruling. While the ban also affected access in states that have secured abortion post-Roe v Wade, a conflicting ruling from Judge Thomas O. Rice from a federal court in Washington state ordered the FDA to maintain access to Mifepristone in 17 democratic states and Colombia District – effectively putting access to the pill into limbo. Mifepristone, which has been FDA-approved for more than 22 years and has a safety record of over 99%[i], is taken alongside the drug Misoprostol during medical abortion procedures. Since then, it has been used by over 5 million[ii] Americans and was used in more than half of abortions nationwide last year. While Misoprostol can be used alone in medical abortion, people should have access to the full spectrum of abortion care options. Mifepristone is also used in the medical management of miscarriage and second and third-trimester pregnancies when the fetus has died before birth. While the ruling does not prohibit the FDA from making a new authorization for Mifepristone, this will likely take many months. Severe disruption to abortion care services, healthcare services and supply chain issues are expected as healthcare providers and pharmacies grapple with legality, stock, retraining and reeducation. Beth Schlachter, Director of Global Advocacy for the International Planned Parenthood Federation, said: "For 22 years, Mifepristone has been safely used in medical abortion care across the U.S., allowing healthcare providers to deliver safe, practical and discreet care to people who have chosen to end their pregnancies, regardless of their economic status or ability to travel. "In one fell swoop, anti-abortion extremists have once again stripped people of their rights in another blow to liberty. This horror ruling based on junk science, wilful distortion of fact and extreme political agendas will profoundly affect the lives of millions of people already struggling to access the care they need, especially in states where abortion is already banned." Anti-abortion extremists deliberately filed the case against the approval of Mifepristone in the Amarillo division of the Northern District of Texas — a single-judge division where cases are automatically assigned to Judge Matthew Kacsmaryk, a conservative judge appointed by former President Trump. The group claim that: "the statutory basis on which the FDA's approval of Mifepristone was issued 22 years ago is invalid" - an assertion both the Government Accountability Office and FDA have previously investigated and put to rest "an 1873 vice law that made it illegal to send "obscene, lewd or lascivious" material through the mail applies to abortion pills" - federal courts have consistently ruled it doesn't apply to lawful abortions "the drug's original approval wasn't supported by evidence of safety and efficacy" — a claim that medical and policy experts have continuously discredited Beth Schlachter, added: "The implementation of a national ban on Mifepristone via a state court debunks one of the principal anti-abortion arguments in the Roe v Wade case  - that the ruling curtailed state freedom and that abortion rights should be defined on a state-by-state basis. "This weaponization of federal courts by anti-abortion extremists proves just how dangerous the overturning of Roe v Wade is for everyday Americans, whose access to healthcare now lies in the hands of fanatical religious extremists determined to disrupt, harass and deceive until they end access to abortion care and long-held sexual and reproductive rights for good." The International Planned Parenthood Federation's local partner, the Planned Parenthood Federation of America, will continue to provide abortion care where safe and legal to do so. Those seeking medical abortion can also access care via AidAccess and WomenonWeb. At least two abortion networks, Trust Women and Whole Womans Health, have also announced that they will not immediately stop prescribing Mifepristone and will await a directive from the FDA – a move known as a conscientious provision which refers to providers who continue to provide care despite the legal parameters.   Alongside its partner and other reproductive health organizations, IPPF will keep fighting for access to abortion care, freedom from stigma and freedom from criminalization until everyone, everywhere, is free to make choices about their sexuality and well-being. [i] https://www.plannedparenthood.org/uploads/filer_public/42/8a/428ab2ad-3798-4e3d-8a9f-213203f0af65/191011-the-facts-on-mifepristone-d01.pdf [ii] Ibid For media enquiries, please contact Karmen Ivey at [email protected] or [email protected]   About the International Planned Parenthood Federation The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.  For 70 years, IPPF, through its 118 Member Associations and seven partners, has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context. We advocate for a world where people have the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.  

Nairobi, Kenya: On 21st March 2023 the Ugandan parliament approved a law which, if enacted, would criminalise people for identifying as a member of the LGBTIQ+ community. The proposed law has been through two readings in parliament and is awaiting a third before it is put forward to the President for Assent. If passed, it will be a gross violation of and undermine the human rights and safety of people identifying as LGBTIQ+ in Uganda. IPPF Africa Region is strongly concerned about the numerous ways in which the passing of this law will violate international human rights including the right to life and dignity, freedom of expression and association, protection from discrimination, and will compromise the full and complete attainment of sexual and reproductive health and rights. Additionally, IPPF is extremely concerned about the dangerous message the law sends. In addition to criminalising consent, it encourages hatred, may escalate violence and gender-based violence targeting persons from LGBTIQ+ communities, popular justice, hinders the right to a fair trial, makes it easier to target minority groups, and harder for them to access justice and redress for hate crimes. At a time when countries around the world and in Africa are decriminalising same sex relationships, this law, if passed, will be a serious step backwards for Uganda. Marie-Evelyne Petrus-Barry, IPPF’s Africa Regional Director, said: "IPPF works to ensure the sexual and reproductive health and rights of all people regardless of their sexual orientation, gender identity and/or expression, and sex characteristics (SOGIESC) – including lesbian, gay, bisexual, trans, and intersex people – and ensure they have access to the full set of human rights enshrined in international human rights laws”  “IPPF is willing to work with the Ugandan Government and other stakeholders to ensure that all Ugandan people can access their sexual and reproductive rights without fear, discrimination, or restraint", added Petrus-Barry. IPPF strongly urges the President of Uganda to not sign off on this discriminatory law, uphold and safeguard the Universal Declaration and African Charter on Human Rights, and treat all Ugandans equally. IPPF stands with the LGBTIQ+ community in Uganda and globally at this difficult time. For further information or to request an interview, please contact: Mahmoud Garga, Lead Specialist - Strategic Communication, Media Relations and Digital Campaigning, IPPF Africa Regional Office (IPPFARO) – email: [email protected] / Tel: +254 704 626 920 ABOUT IPPF AFRICA REGION (IPPFAR) The International Planned Parenthood Federation Africa Region (IPPFAR) is one of the leading sexual and reproductive health (SRH) service delivery organization in Africa, and a leading sexual and reproductive health and rights (SRHR) advocacy voice in the region. Headquartered in Nairobi, Kenya, the overarching goal of IPPFAR is to increase access to SRHR services to the most vulnerable youth, men and women in sub-Saharan Africa. Supported by thousands of volunteers, IPPFAR tackles the continent’s growing SRHR challenges through a network of Member Associations (MAs) in 40 countries. We do this by developing our MAs into efficient entities with the capacity to deliver and sustain high quality, youth focused and gender sensitive services. We work with Governments, the African Union, Regional Economic Commissions, the Pan-African Parliament, United Nations bodies among others to expand political and financial commitments to sexual and reproductive health and rights in Africa. Learn more about us on our website. Follow us on Facebook, Twitter, Instagram and You Tube.  

Profamilia – an IPPF Member Association and the leading sexual and reproductive rights organization in Colombia – is celebrating the first anniversary of the decriminalization of abortion across the country. The move - Ruling C-055 - which allows abortion up to 24 weeks of gestation under any circumstance is saving lives across Colombia, and means those who have an abortion no longer face prosecution or criminalization. A historic step for the rights of women and pregnant people both in the country and across Latin America. Over the last year, Profamilia via its nationwide network of more than 50 clinics has helped guarantee sexual and reproductive health and rights, focusing on providing safe abortion care services in person as well as the provision of telemedicine for rural women.   For a country which sees 132,000 cases annually of complications from unsafe abortions and 70 women lose their lives each year – the shift in focus to abortion as a public health issue means healthcare providers can now focus on providing life-saving care and ending unsafe abortion. Alongside the ruling, the Ministry of Health, has also regulated abortion services throughout Colombia via Resolution 051, reiterating that abortion is an essential and urgent health service, which women, including migrant women, and pregnant people (transgender men, trans masculinities, non-binary people, among others) must be able to access without restriction and for free. Further rulings also embeds the provision of sexual and reproductive health information into Colombian health services. Marta Royo, the Executive Director of ProFamilia, said: "Profamilia's commitment will always be to provide comprehensive, humanized and safe services that allow free and informed decision making, and we reiterate this today” "After one year it is possible to see the progress the country has made in terms of reproductive autonomy and rights for women and pregnant people. However, we must move from text to action, and ensure that decriminalization means healthcare. Profamilia's commitment will always be to provide comprehensive, humanized and safe services that allow free and informed decision making." Eugenia López Uribe, Regional Director of IPPF for the Americas and The Caribbean.